The Netherlands has become the latest country to suspend use of the Oxford-AstraZeneca coronavirus vaccine over concerns about possible side effects.
The Dutch government said the move, which will last until at least 29th March, was a precaution.
The Republic of Ireland earlier made a similar decision over reports of blood clotting events in adults in Norway.
But the World Health Organization says there is no link between the jab and an increased risk of developing a clot.
The European Medicines Agency (EMA) which is currently carrying out a review into incidents of blood clots says the vaccine’s benefits continue to outweigh its risks.